The Mark Foundation for Cancer Research
A philanthropic funder that backs high-risk cancer biology, tumour-immunology and computational projects and invests in start-ups translating them.
Founded in 2017 by Alex Knaster, the Mark Foundation funds cancer research through Emerging Leader Awards for early-career investigators, Endeavor Awards for multi-institution team science, ASPIRE awards for high-risk ideas, and the Mark Foundation Institutes and centres at institutions including the Francis Crick Institute, Cambridge and Yale. It has an active venture arm that invests in companies emerging from funded science. Priority areas include the mechanisms of drug resistance, metastasis, tumour-immune interactions, early detection and computational oncology, and it partners with AACR, Cancer Research UK and the Damon Runyon Foundation on joint programmes.
- Emerging Leader Awards
- Endeavor team-science awards
- ASPIRE high-risk awards
- Venture investments
Pages like this
not linked directly; found by shared links- PersonIain Foulkes
- PersonMichelle Mitchell
- InstitutionEuropean Association for Cancer Research
Shares American Association for Cancer Research (AACR), The valley of death between lab and product, Cancer Research UK.
- IdeaA national rapid research autopsy network for end-stage cancer
Shares The Francis Crick Institute, Metastasis is understood least and studied last, Cancer Research UK.
- IdeaA public-benefit phase 1 factory that takes academic discoveries into first-in-human trials
Shares The Francis Crick Institute, The valley of death between lab and product.
- InstitutionWorldwide Cancer Research
Shares The valley of death between lab and product, Cancer Research UK.
- IdeaPool every multi-sample tumour genome into one open evolution atlas
- InstitutionStand Up To Cancer
Shares American Association for Cancer Research (AACR), The valley of death between lab and product, Cancer Research UK.